As of January 23, 2025, Biofrontera (BFRI) has a market cap of $7.904 million USD. According to our data, Biofrontera is ranked No.8940 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $7.90 M |
-6.42%
|
Dec 31, 2024 | $8.45 M |
-60.65%
|
Dec 29, 2023 | $21.47 M |
-84.90%
|
Dec 30, 2022 | $0.14 B |
-87.81%
|
Dec 31, 2021 | $1.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Bio-Techne
TECH
|
$12.51 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Market Cap | = | BFRI Stock Price | * | BFRI Shares Outstanding |
= | $1.02 | * | 7.75 M | |
= | $7.90 M |